Literature DB >> 28637315

Attenuated Effects of Bile Acids on Glucose Metabolism and Insulin Sensitivity in a Male Mouse Model of Prenatal Undernutrition.

Huijuan Ma1,2, Vicencia M Sales1, Ashley R Wolf3, Sathish Subramanian3, Tucker J Matthews1, Michael Chen1, Aparna Sharma1, Walt Gall4, Wim Kulik5, David E Cohen6, Yusuke Adachi1, Nicholas W Griffin3, Jeffrey I Gordon3, Mary-Elizabeth Patti1, Elvira Isganaitis1.   

Abstract

Prenatal undernutrition and low birth weight are associated with risk of type 2 diabetes and obesity. Prenatal caloric restriction results in low birth weight, glucose intolerance, obesity, and reduced plasma bile acids (BAs) in offspring mice. Because BAs can regulate systemic metabolism and glucose homeostasis, we hypothesized that BA supplementation could prevent diet-induced obesity and glucose intolerance in this model of developmental programming. Pregnant dams were food restricted by 50% from gestational days 12.5 to 18.5. Offspring of both undernourished (UN) and control (C) dams given unrestricted diets were weaned to high-fat diets with or without supplementation with 0.25% w/w ursodeoxycholic acid (UDCA), yielding four experimental groups: C, UN, C + UDCA, and UN + UDCA. Glucose homeostasis, BA composition, liver and intestinal gene expression, and microbiota composition were analyzed in the four groups. Although UDCA supplementation ameliorated diet-induced obesity in C mice, there was no effect in UN mice. UDCA similarly lowered fasting insulin, and improved glucose tolerance, pyruvate tolerance, and liver steatosis in C, but not UN, animals. BA composition differed significantly, and liver and ileal expression of genes involved in BA metabolism (Cyp7b1, Shp) were differentially induced by UDCA in C vs UN animals. Bacterial taxa in fecal microbiota correlated with treatment groups and metabolic parameters. In conclusion, prenatal undernutrition alters responsiveness to the metabolic benefits of BA supplementation, with resistance to the weight-lowering and insulin-sensitizing effects of UDCA supplementation. Our findings suggest that BA metabolism may be a previously unrecognized contributor to developmentally programmed diabetes risk.
Copyright © 2017 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28637315      PMCID: PMC5551557          DOI: 10.1210/en.2017-00288

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  61 in total

1.  Impaired biliary lipid secretion in obese Zucker rats: leptin promotes hepatic cholesterol clearance.

Authors:  S VanPatten; N Ranginani; S Shefer; L B Nguyen; L Rossetti; D E Cohen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-08       Impact factor: 4.052

Review 2.  An Intestinal Microbiota-Farnesoid X Receptor Axis Modulates Metabolic Disease.

Authors:  Frank J Gonzalez; Changtao Jiang; Andrew D Patterson
Journal:  Gastroenterology       Date:  2016-09-14       Impact factor: 22.682

3.  Maternal Calorie Restriction Causing Uteroplacental Insufficiency Differentially Affects Mammalian Placental Glucose and Leucine Transport Molecular Mechanisms.

Authors:  Amit Ganguly; Marlin Touma; Shanthie Thamotharan; Darryl C De Vivo; Sherin U Devaskar
Journal:  Endocrinology       Date:  2016-08-05       Impact factor: 4.736

4.  Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled Trial.

Authors:  Dorien Reijnders; Gijs H Goossens; Gerben D A Hermes; Evelien P J G Neis; Christina M van der Beek; Jasper Most; Jens J Holst; Kaatje Lenaerts; Ruud S Kootte; Max Nieuwdorp; Albert K Groen; Steven W M Olde Damink; Mark V Boekschoten; Hauke Smidt; Erwin G Zoetendal; Cornelis H C Dejong; Ellen E Blaak
Journal:  Cell Metab       Date:  2016-07-12       Impact factor: 27.287

5.  Bile acids in the serum and duodenal content of newborn infants of different classification.

Authors:  H Senger; G Boehm; K Beyreiss; W Braun
Journal:  Biomed Biochim Acta       Date:  1986

6.  Structural insights into gene repression by the orphan nuclear receptor SHP.

Authors:  Xiaoyong Zhi; X Edward Zhou; Yuanzheng He; Christoph Zechner; Kelly M Suino-Powell; Steven A Kliewer; Karsten Melcher; David J Mangelsdorf; H Eric Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-30       Impact factor: 11.205

7.  Gut microbiome diversity and high-fibre intake are related to lower long-term weight gain.

Authors:  C Menni; M A Jackson; T Pallister; C J Steves; T D Spector; A M Valdes
Journal:  Int J Obes (Lond)       Date:  2017-03-13       Impact factor: 5.095

8.  Polysome profiling in liver identifies dynamic regulation of endoplasmic reticulum translatome by obesity and fasting.

Authors:  Suneng Fu; Jason Fan; Joshua Blanco; Alfredo Gimenez-Cassina; Nika N Danial; Steve M Watkins; Gökhan S Hotamisligil
Journal:  PLoS Genet       Date:  2012-08-23       Impact factor: 5.917

9.  Diet and specific microbial exposure trigger features of environmental enteropathy in a novel murine model.

Authors:  Eric M Brown; Marta Wlodarska; Benjamin P Willing; Pascale Vonaesch; Jun Han; Lisa A Reynolds; Marie-Claire Arrieta; Marco Uhrig; Roland Scholz; Oswaldo Partida; Christoph H Borchers; Philippe J Sansonetti; B Brett Finlay
Journal:  Nat Commun       Date:  2015-08-04       Impact factor: 14.919

10.  Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes.

Authors:  Moran Yassour; Mi Young Lim; Hyun Sun Yun; Timothy L Tickle; Joohon Sung; Yun-Mi Song; Kayoung Lee; Eric A Franzosa; Xochitl C Morgan; Dirk Gevers; Eric S Lander; Ramnik J Xavier; Bruce W Birren; GwangPyo Ko; Curtis Huttenhower
Journal:  Genome Med       Date:  2016-02-17       Impact factor: 11.117

View more
  8 in total

Review 1.  Renin-Angiotensin System in Liver Metabolism: Gender Differences and Role of Incretins.

Authors:  Zainab Mastoor; Yolanda Diz-Chaves; Lucas C González-Matías; Federico Mallo
Journal:  Metabolites       Date:  2022-05-03

Review 2.  Targeting the alternative bile acid synthetic pathway for metabolic diseases.

Authors:  Wei Jia; Meilin Wei; Cynthia Rajani; Xiaojiao Zheng
Journal:  Protein Cell       Date:  2020-11-30       Impact factor: 14.870

3.  Bromodomain Inhibition Reveals FGF15/19 As a Target of Epigenetic Regulation and Metabolic Control.

Authors:  Chisayo Kozuka; Vissarion Efthymiou; Vicencia M Sales; Liyuan Zhou; Soravis Osataphan; Yixing Yuchi; Jeremy Chimene-Weiss; Christopher Mulla; Elvira Isganaitis; Jessica Desmond; Suzuka Sanechika; Joji Kusuyama; Laurie Goodyear; Xu Shi; Robert E Gerszten; Cristina Aguayo-Mazzucato; Priscila Carapeto; Silvania DaSilva Teixeira; Darleen Sandoval; Direna Alonso-Curbelo; Lei Wu; Jun Qi; Mary-Elizabeth Patti
Journal:  Diabetes       Date:  2022-05-01       Impact factor: 9.337

4.  The acidic pathway of bile acid synthesis: Not just an alternative pathway.

Authors:  William M Pandak; Genta Kakiyama
Journal:  Liver Res       Date:  2019-05-21

5.  The role of CD36-Fabp4-PPARγ in skeletal muscle involves insulin resistance in intrauterine growth retardation mice with catch-up growth.

Authors:  Jing Liu; Hang Zhao; Linlin Yang; Xing Wang; Linquan Yang; Yuling Xing; Xiuqin Lv; Huijuan Ma; Guangyao Song
Journal:  BMC Endocr Disord       Date:  2022-01-04       Impact factor: 2.763

Review 6.  Roles of gut microbiota and metabolites in overweight and obesity of children.

Authors:  Shengan Zhang; Yanqi Dang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-08       Impact factor: 6.055

7.  Exploring the Multi-Tissue Crosstalk Relevant to Insulin Resistance Through Network-Based Analysis.

Authors:  Linlin Yang; Linquan Yang; Xing Wang; Hanying Xing; Hang Zhao; Yuling Xing; Fei Zhou; Chao Wang; Guangyao Song; Huijuan Ma
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-18       Impact factor: 5.555

8.  Adipose Dysfunction in Adulthood Insulin Resistance of Low-Birth Weight Mice: A Proteomics Study.

Authors:  Huijuan Ma; Guangyao Song; Jun Wang; Linlin Yang; Linquan Yang; Fei Zhou; Hang Zhao; Jing Liu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-03-16       Impact factor: 3.168

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.